Effects of Point Mutations in Plasmodium falciparum Dihydrofolate Reductase and Dihydropterate Synthase Genes on Clinical Outcomes and In Vitro Susceptibility to Sulfadoxine and Pyrimethamine
David J. Bacon, Doug Tang, Carola Salas et al. · 2009
Read Effects of Point Mutations in Plasmodium falciparum Dihydrofolate Reductase and Dihydropterate Synthase Genes on Clinical Outcomes and In Vitro Susceptibility to Sulfadoxine and Pyrimethamine by David J. Bacon, Doug Tang, Carola Salas et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006762.txt.
Description
David J. Bacon and his team linked gene changes in malaria parasites to drug failure in PLOS ONE in 2009. A drug pair, sulfadoxine with pyrimethamine, once led the fight against falciparum malaria. It failed more and more as parasites grew resistant. Many lands switched to new drug pairs. Resistance comes from small changes in two parasite genes.
The team checked how each change shaped patient outcomes. They also tested the drugs on parasites in the lab. Gene checks can warn clinics which failures to expect. That sharpens the watch for resistance in each land. It helps health programs know when a drug is spent and must be dropped.
Catalog record
| CREATOR | David J. Bacon, Doug Tang, Carola Salas et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| LICENSE | Creative Commons CC0 License |
| RIGHTS | CC0 |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006762